Ahmed Khattab, MD
- Autoimmune Hypothyroidism
- Congenital Adrenal Hyperplasia
- Congenital Hypothyroidism
- Delayed Puberty
- Disorders of the Adrenal, Ovary and Testis
- Growth Failure
- Growth Hormone Deficiency
- Hypogonadotropic Hypogonadism
- Controversies surrounding female athletes with differences in sexual development
- Disorders of the Adrenal Cortex in the Fetus and Neonate
- McCune–Albright syndrome and type 1 diabetes mellitus: a novel presentation
- Management of congenital adrenal hyperplasia: Beyond conventional glucocorticoid therapy
- Obesity in Adolescents and Youth: The Case for and against Bariatric Surgery
- Fertility in patients with nonclassical congenital adrenal hyperplasia
- Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation
- Anovelde novo frameshift mutation in NR0B1 and low prenatal estriol in adrenal hypoplasia congenita
- Prenatal diagnosis and treatment of genetic steroid disorders
- CYP21A2 genetic profile in 14 Egyptian children with suspected congenital adrenal hyperplasia: a diagnostic challenge
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Khattab has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.